more_reports

Ngaere-2 Well Beats Expectations, Tariki Gas Storage Offer Imminent

Research Report
  ()
Auctus Advisors raised its target price on New Zealand Energy Corp. (NZ:TSX.V; NZERF:OTCQX) after the Ngaere-2 well recompletion delivered 300 bbl/d, exceeding expectations.

Energy Co. Begins KW1X Production Testing in Namibia: Six Zones, 346 MMbbl Upside and a 349% Target Return

Research Report
  ()
Research Capital reaffirmed its rating and target on Reconnaissance Energy Africa Ltd. (RECO:TSXV; RECAF:OTCQX; 0XD:FSE) as production testing kicked off at the KW1X well in Namibia.

Biotech Price Target Raised on Strong FSHD and DM1 siRNA Data

Research Report
  ()
Wedbush Securities raised its price target on Sarepta Therapeutics Inc. (SRPT:NASDAQ), following promising Phase 1/2 data for siRNA candidates SRP-1001 in FSHD and SRP-1003 in DM1, citing superior muscle concentration and a clean safety profile versus rival programs from Novartis and Dyne Therapeutics.

Rare Disease Biotech Sell Rating Maintained: Early Clinical Data Fails to Offset Flagship Drug Revenue Decline

Research Report
  ()
H.C. Wainwright reiterated a Sell rating on Sarepta Therapeutics Inc. (SRPT:NASDAQ), arguing that promising but early-stage siRNA muscle concentration data in DM1 and FSHD cannot compensate for falling ELEVIDYS sales, a fatal adverse event in SRP-1003, and intensifying competition from Avidity and Dyne ahead of a potential 2030 market entry.

Buy Rating Reaffirmed: ALTO-207 TRD Trial on Track

Research Report
  ()
Stifel reiterated its rating and price target on Alto Neuroscience Inc. (ANRO:NYSE) after an in-line Q4 2025 earnings report.

Neuroscience Co. Enters Catalyst-Rich 2026 With Multiple Phase 2 Readouts and US$120M Financing

Research Report
  ()
H.C. Wainwright reiterated its rating and price target on Alto Neuroscience Inc. (ANRO:NYSE), citing upcoming Phase 2 data readouts for ALTO-101, ALTO-300, and ALTO-100, plus US$120 million financing to advance ALTO-207 in treatment-resistant depression through Phase 3.

Sleeping Giant Mine Hits First Profitable Quarter and Glencore Deal Secures Funding

Research Report
  ()
Couloir Capital raised its fair value estimate on Abcourt Mines Inc. (ABI:TSX.V; ABMBF:OTCPK), citing the Sleeping Giant mine's first profitable quarter, a US$30 million Glencore financing and offtake deal, and advancing exploration at Flordin.
Tags: Gold

Sangdong Mine Commissioning and Surging Tungsten Prices Set the Stage for Transformational 2026 Growth

Research Report
  ()
Almonty Industries Inc. (AII:TSX; ALM:NASDAQ; ALL:ASX; ALI:Frankfurt) completed Phase 1 commissioning at its flagship Sangdong tungsten mine in South Korea, with tungsten prices hitting all-time highs above US$2,000/tonne, stated an Alliance Global research note.

Gold Co. Advancing Toward PFS and Near-Term Production

Research Report
  ()
Red Cloud Securities reviewed Lake Victoria Gold Ltd.'s (LVG:TSX; LVGLF:OTCQB; E1K:FSE) metallurgical test results at Imwelo, highlighting high gold recoveries, a conventional processing flowsheet, and upcoming catalysts, including an updated MRE in 2026 and PFS in 2027.
Tags: Gold

Gold Co. Confirms 97% Gold Recovery at Imwelo, Construction on Track for 2026 as Key Catalysts Approach

Research Report
  ()
Lake Victoria Gold Ltd.'s (LVG:TSX; LVGLF:OTCQB; E1K:FSE) metallurgy testwork confirmed up to 97% gold recoveries at the fully permitted Imwelo Project, with construction targeted for later in 2026, first gold expected in 2027, and ongoing Barrick drilling at Tembo offering additional upside, according to an Atrium Research note.
Tags: Gold

Lithium Co.'s Low-Cost Profile and Mitsui Offtake Agreement Drive M&A Interest

Research Report
  ()
H.C. Wainwright raised its price target on Atlas Lithium Corp. (ATLX:NASDAQ), citing a sub-US$500/tonne cost structure and strong strategic interest from global lithium majors as key catalysts for the development-stage miner.

Langhorne, PA Biotech Eyes Mid-2026 Molbreevi Launch

Research Report
  ()
H.C. Wainwright reiterated its rating and price target on Savara Inc. (SVRA:NASDAQ), citing a cleared regulatory path for Molbreevi with an August 22, 2026, PDUFA date, no planned FDA Advisory Committee, and accelerating commercial preparations targeting 1,700 accounts and 4,500 healthcare professionals ahead of a potential approval in the rare autoimmune PAP market.

Bothell, WA Bio Co. Poised for 17-20% Revenue Growth in 2026 as Cell Therapy Market Expands

Research Report
  ()
BioLife Solutions Inc. (BLFS:NASDAQ) reported strong 2025 results. The company is now a pure-play cell processing business, expecting double-digit growth driven by expanding cell and gene therapy adoption, according to an H.C. Wainwright & Co. research note.

Gold Exploration Co. Acquires District-Scale Gold-Silver Project in Esmeralda County, Nevada

Research Report
  ()
A2Gold Corp. (AUAU:TSXV; AUXXF:OTCQX; RR7:FSE) announced the acquisition of the Taylor Gold-Silver Project, adding 11Moz M&I silver resource and significant exploration upside in Nevada, according to an Atrium Research note.
Tags: Gold

Analyst Maintains Spec Buy on Biotech After Interim SAT-3247 DMD Data

Research Report
  ()
Leede Financial maintained its rating on Satellos Bioscience Inc. (MSCL:TSX; MSLE:NASDAQ), with a US$16.00 price target following updated interim Phase II SAT-3247 data from the TRAILHEAD trial in Duchenne muscular dystrophy.

South Dakota Energy Co. Shares Poised to Nearly Double on Rising Uranium Production and Dewey Burdock Progress

Research Report
  ()
HoldCo Markets sees 85% upside for EnCore Energy Corp. (EU:TSX.V; ENCUF:OTCQX) shares, driven by strong FY2025 results, ramping production from Alta Mesa, and the advancement of the large-scale Dewey Burdock uranium project in South Dakota.
Tags: Uranium

Expert Investing Ideas

"TORR nearly doubled the size of the Sonic copper-gold soil anomaly."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"As of early 2026, GOT holds more than $50M in cash."

–John Newell, John Newell & Associates


"WEX is continuing to progress along its two-pronged strategy."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"Drilling is ongoing at DRY's Pearl zone as well as the Hyndman target."

–Brien Lundin, Gold Newsletter (Jefferson Financial)


"We are initiating coverage on ATCX with a Buy rating."

–Jake Sekelsky, Alliance Global Partners


"WRLG's Rowan results add confidence in the project."

–Jeff Clark, TheGoldAdvisor.com


"LGD offers a compelling asymmetric opportunity."

–Lauren McConnell, Paradigm Capital


Company News

SYH:TSX.V; SYHBF:OTCQX; SC1P:FSE
4/1/2026 – Skyharbour Announces Drilling Underway and Renewed Permit at the High-Grade Moore Lake Uranium Project, Saskatchewan

SPAI:CSE; SPAIF:OTCQB; 5OVO:Frankfurt
4/1/2026 – SPARC AI Expands Overwatch Distribution with App Launch and Indian Defence Trial Engagement

SF:TSX; PNTZF:OTCQB; TZU2:FRA
4/1/2026 – Trigon Metals Announces Name Change to Safi Silver

LVG:TSX; LVGLF:OTCQB; E1K:FSE
4/1/2026 – Lake Victoria Gold Secures up to a ~US$25 Million Gold Loan from Monetary Metals plus Fully Committed $3.0 Million Convertible Debenture Financing

AGN:CSE; AGNPF:OTCQB; AGW0:XFRA
3/31/2026 – Algernon Health Announces Proposed Name Change to "Grey Matters Health Inc." and a 10:1 Share Consolidation

SF:TSX; PNTZF:OTCQB; TZU2:FRA
3/31/2026 – Trigon Metals Announces Receipt of First Horizon Payment

SEA:TSX; SA:NYSE.MKT
3/31/2026 – Seabridge Gold Provides Updated Mineral Resource Estimates for KSM Project

ADZ:TSX.V
3/31/2026 – Adamera Stakes Tungsten Ridge, Washington State, U.S.A., adding to its Critical Minerals Portfolio

MATA:TSX.V; MATAF:OTCQB;IU3:FSE
3/31/2026 – Matador Technologies Announces Launch of Bitcoin Yield Strategy with Galaxy and C-Suite Promotions

GWM:TSX.V; GAYMF:OTCQB
3/31/2026 – Galway Metals Intersects Thick Gold-Antimony Mineralization at South Deposit, Including 6.1 g/t Au and 0.7% Sb Over 28.0m

WRLG:TSX.V; WRLGF:OTCQX; UJO:FSE
3/31/2026 – West Red Lake Gold Adding Confidence to Rowan Mine Resource and Extending Vein Zones

ARMY:CSE; RMRYF:OTC; J2S:FRA
3/30/2026 – Armory Mining Applies To Canadian Association Of Defence And Security Industries To Advance Its Critical Minerals Strategy

Streetwise Reader Icon Streetwise Key Charts
Gold Silver Copper Zinc Oil Gas Natural Gas Battery Metals Coal Uranium Pharma Biotech & Life Sci

Get Our Streetwise Reports' Research Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

Medical Co.'s TULSA-PRO Installed Base Growth and CAPTAIN Trial Data Could Accelerate Adoption in 2026"

Research Report
  ()
Leede Financial maintained its rating on Profound Medical Corp. (PROF:NASDAQ; PRN:TSX), citing strong TULSA-PRO capital sales, expanding installed base, and upcoming CAPTAIN trial results at EAU meeting as key catalysts.

Target Raised on CA Pharma Co. as EBITDA Margins Sustain Upward Trajectory

Research Report
  ()
Leede Financial maintains its current rating on CareRx and raised its target price, following FQ425 results showing continued sequential improvement in EBITDA, margins, and operating cash flow.

Record Profits, a Vape Market Landgrab, and a CA$250M Facility Bought for CA$27M

Research Report
  ()
Atrium Research initiated coverage on Cannara Biotech Inc. (LOVE:TSX; LOVFF:OTCQX; BCB0:FSE), citing the company's dominant position in Quebec's new vape category, best-in-class EBITDA margins of 29%, and a capital-efficient expansion path at its Valleyfield facility that could unlock 100,000 kg of annual production capacity by FY30.

Multi-Domain USV-Drone Platform, US$2B Funding Opportunity, and Capacity Expansion Drive 2026 Growth Outlook

Research Report
  ()
Needham reiterated its rating on Red Cat Holdings Inc. (RCAT:NASDAQ) after Innovation Day showcased coordinated USV-drone operations, highlighted over US$2 billion in appropriated DoW funding, and demonstrated aggressive manufacturing capacity expansion across three facilities targeting profitability by 2027.

Energy Co. Triples Welchau Gas Resources With Deeper Duplex Array Discovery, Eyes FY26 Well Re-Entry Catalyst

Research Report
  ()
ADX Energy Ltd. (ADXRF:OTCMKTS; ADX:ASX) sees its Welchau prospective gas resources surge more than threefold following the incorporation of the deeper Duplex Array 2 interval, with a planned FY26 well re-entry offering two high-value catalysts, according to an Auctus Advisors research note.